TWEIX
Price
$9.00
Change
-$0.00 (-0.00%)
Updated
Jun 9 closing price
Net Assets
6.41B
VIVAX
Price
$83.40
Change
+$0.47 (+0.57%)
Updated
Jun 9 closing price
Net Assets
245.01B
Interact to see
Advertisement

TWEIX vs VIVAX

Header iconTWEIX vs VIVAX Comparison
Open Charts TWEIX vs VIVAXBanner chart's image
TWEIX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
TWEIX vs. VIVAX commentary
Jun 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TWEIX is a Buy and VIVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 245B vs. TWEIX (6.41B). TWEIX pays higher dividends than VIVAX: TWEIX (2.09) vs VIVAX (1.76). TWEIX was incepted earlier than VIVAX: TWEIX (32 years) vs VIVAX (34 years). TWEIX (0.94) is less costly to investors than VIVAX (0.17). TWEIX is a more actively managed with annual turnover of: 38.00 vs. VIVAX (8.00). VIVAX has a lower initial minimum investment than TWEIX: VIVAX (0) vs TWEIX (2500). VIVAX annual gain was more profitable for investors over the last year : 22.89 vs. TWEIX (7.87). VIVAX return over 5 years is better than : 52.07 vs. TWEIX (1.94).
TWEIXVIVAXTWEIX / VIVAX
Total Expense Ratio0.940.17553%
Annual Report Gross Expense Ratio0.940.17553%
Fund Existence32 years34 years-
Gain YTD7.67711.27168%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.41B245B3%
Annual Yield % from dividends2.091.76119%
Returns for 1 year7.8722.8934%
Returns for 3 years10.4352.4520%
Returns for 5 years1.9452.074%
Returns for 10 years27.87151.2718%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKY38.790.83
+2.19%
Rocky Brands
ADI404.620.73
+0.18%
Analog Devices
MRCY108.82-2.12
-1.91%
Mercury Systems
HLX9.50-0.24
-2.46%
Helix Energy Solutions Group
PAVM4.68-0.50
-9.65%
PAVmed Inc